Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review
| Author | Reza Ganji | en |
| Author | Shahram Ala | en |
| Author | Mohsen Aarabi | en |
| Author | Babak Baghery | en |
| Author | Ebrahim Salehifar | en |
| Issued Date | 2016-04-30 | en |
| Abstract | Acute Venous Thromboembolism (VTE) is a common disease associated with the significant morbidity and mortality. We reviewed clinical outcomes systematically with Dabigatran as a direct oral anticoagulants (DOAC) for treatment of acute VTE. We used Ovide, PubMed, Cochrane (CENTRAL), EMBASE, Scopus, Science Direct, LILAC(for article written not English) and also Iranian database; Magiran, Isc, Iran Medex, Iran DOC, Doaj up to May 2014 to identify randomized clinical trials of Dabigatran compared with conventional treatment for VTE. Two investigators extracted data independently. | en |
| DOI | https://doi.org/10.22037/ijpr.2016.1867 | en |
| Keyword | Dabigatran | en |
| Keyword | Warfarin | en |
| Keyword | Venous Thromboembolism | en |
| Keyword | direct oral anticoagulants | en |
| Keyword | VTE | en |
| Publisher | Brieflands | en |
| Title | Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review | en |
| Type | Original Article | en |